Lista de obras -

A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke

article

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry

artículo científico publicado en 2005

Affected twins in the familial intracranial aneurysm study

artículo científico publicado en 2015

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial

artículo científico publicado en 2013

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

artículo científico publicado en 2019

Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage

artículo científico publicado en 2005

Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience

artículo científico publicado en 2014

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial.

artículo científico publicado en 2014

Common mitochondrial sequence variants in ischemic stroke

artículo científico publicado en 2010

Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage

artículo científico publicado en 2013

Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergency department?

artículo científico

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity

artículo científico publicado en 2012

Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial

artículo científico publicado en 2015

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial

artículo científico publicado en 2014

Effect of untreated hypertension on hemorrhagic stroke

artículo científico publicado en 2004

Emergency department arrival times after acute ischemic stroke during the 1990s

artículo científico publicado en 2007

Emergency medical services use by stroke patients: a population-based study

artículo científico publicado en 2009

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

artículo científico publicado en 2016

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Nether

artículo científico publicado en 2015

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

artículo científico publicado en 2016

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

artículo científico publicado en 2014

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke

artículo científico publicado en 2013

Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial

artículo científico publicado en 2014

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials

artículo científico publicado en 2014

Familial intracranial aneurysms: is anatomic vulnerability heritable?

artículo científico publicado en 2012

Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study

artículo científico publicado en 2002

Genome screen in familial intracranial aneurysm

Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study

artículo científico publicado en 2008

Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk

artículo científico publicado en 2012

Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms

artículo científico publicado en 2009

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

artículo científico publicado en 2010

Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study

artículo científico publicado en 2004

Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study

Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites

artículo científico publicado en 2004

Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).

artículo científico

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

artículo científico publicado en 2003

Major risk factors for intracerebral hemorrhage in the young are modifiable

artículo científico publicado en 2005

Mortality and causes of death in the Familial Intracranial Aneurysm study

artículo científico publicado en 2012

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

artículo científico publicado en 2017

Patient-level and hospital-level determinants of the quality of acute stroke care: a multilevel modeling approach

scientific article published on 21 October 2010

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensi

artículo científico publicado en 2015

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial

artículo científico publicado en 2014

Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke

artículo científico publicado en 2012

Reply:

artículo científico publicado en 2017

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project

artículo científico publicado en 2012

Stroke in a biracial population: the excess burden of stroke among blacks

artículo científico publicado en 2004

Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association

artículo científico publicado en 2014

Subarachnoid hemorrhage: a preventable disease with a heritable component

artículo científico publicado en 2002

The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes.

artículo científico publicado en 2006

The effect of race and gender on patterns of rt-PA use within a population.

artículo científico publicado en 2003

The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm

artículo científico publicado en 2010

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

artículo científico publicado en 2014

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

artículo científico publicado en 2015

Unruptured intracranial aneurysms in the Familial Intracranial Aneurysm and International Study of Unruptured Intracranial Aneurysms cohorts: differences in multiplicity and location

artículo científico publicado en 2012

Lista de obras de

A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry

Affected twins in the familial intracranial aneurysm study

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage

Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial.

Common mitochondrial sequence variants in ischemic stroke

Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage

Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergency department?

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity

Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial

Effect of untreated hypertension on hemorrhagic stroke

Emergency department arrival times after acute ischemic stroke during the 1990s

Emergency medical services use by stroke patients: a population-based study

Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Nether

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke

Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials

Familial intracranial aneurysms: is anatomic vulnerability heritable?

Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study

Genome screen in familial intracranial aneurysm

Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study

Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk

Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study

Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study

Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites

Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

Major risk factors for intracerebral hemorrhage in the young are modifiable

Mortality and causes of death in the Familial Intracranial Aneurysm study

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III

Patient-level and hospital-level determinants of the quality of acute stroke care: a multilevel modeling approach

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensi

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial

Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke

Reply:

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project

Stroke in a biracial population: the excess burden of stroke among blacks

Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association

Subarachnoid hemorrhage: a preventable disease with a heritable component

The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes.

The effect of race and gender on patterns of rt-PA use within a population.

The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial

Unruptured intracranial aneurysms in the Familial Intracranial Aneurysm and International Study of Unruptured Intracranial Aneurysms cohorts: differences in multiplicity and location